Updates in Myelodysplastic Syndromes
Updates in Myelodysplastic Syndromes is organized by Physicians' Education Resource, LLC (PER).
Release Date: April 10, 2023
Expiration Date: April 10, 2024
Description:
This brief online educational activity is designed to place key updates from recent studies in the management of myelodysplastic syndromes (MDS), with particular focus on emerging treatment options for higher-risk disease. The multimedia format includes an audio interview with Eytan Stein, MD, who provides a summary of the key findings from these studies and places them into the context of clinical practice.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Outline current and emerging diagnostic strategies for predictive and prognostic biomarkers that best inform treatment decision-making in patients with MDS and leukemias
• Evaluate recent safety and efficacy data of agents/combinations investigated in patients with MDS and leukemias
• Assess recent evidence from clinical trials evaluating approved and emerging therapies within the context of evolving treatment paradigms for patients with MDS and leukemias.